Pfizer eyes IPO of animal health division
Drug company hopes to raise $3 billion from its £11 billion division
By CFOWorld.co.uk | CFO UK | Published 10:59, 20 February 12
Drugs company Pfizer is weighing up a potential initial public offering of its animal health division valued at £11 billion, reports suggested on Monday.
the company is hoping to raise around $3 billion from the IPO, which it has opened discussions about, the Financial Times reported. Pfizer would look to place up to 19.9 percent of the unit's shares in the autumn.
Pfizer's animal health division is the largest in the world. It said it was still evaluation all options for the division, which had been criticised for poor returns. However, a full blown sale would be likley to incur a large tax hit.
Share:Facebook Twitter Google Plus Stumble Upon Reddit Share This Email this article
Outdated finance processes, systems and competencies leave too many questions unansweredmore ..
public sector net debt equalled 77.3 percent of GDP, the ONS said.more ..
Despite government efforts to boost exports, the survey found that export were flat in the quarter to Julymore ..
CEO Moya Greene was however confident of meeting full-year expectations despite weak performance in parcels deliveriesmore ..
CFOs are keen for the chancellor to avoid any uncertaintymore ..
CFOs used to low interest rates ignore working capital optimisation at their perilmore ..